EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of AIDS-associated non-Hodgkins lymphoma by gallium nitrate



Treatment of AIDS-associated non-Hodgkins lymphoma by gallium nitrate



Official Gazette of the United States Patent & Trademark Office Patents 1270(2), May 13



The present invention comprises an improved method of treatment of AIDS-associated non-Hodgkin's lymphoma by administering gallium nitrate in a pharmaceutically acceptable vehicle.

(PDF emailed within 1 workday: $29.90)

Accession: 035980311

Download citation: RISBibTeXText



Related references

Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate. Journal of Pharmacology and Experimental Therapeutics 322(3): 1228-1236, 2007

Identification of biomarkers for tumor sensitivity and resistance to the antineoplastic drug gallium nitrate in non-Hodgkins lymphoma. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1152, July, 2003

Continuous infusion gallium nitrate in refractory AIDS associated lymphoma. JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A40, May 1, 1999

Localization of hodgkins disease and non hodgkins lymphoma by gallium 67 subtraction scanning. Onkologie 1(1): 24-30, 1978

Gallium-67 imaging A predictor of residual tumor viability and clinical outcome in Hodgkins and non-Hodgkins lymphoma patients. Journal of Nuclear Medicine 40(5 SUPPL ): 62P, 1999

Gallium nitrate in the treatment of lymphoma. Seminars in Oncology 30(2 Suppl 5): 25-33, 2003

Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate. Molecular Cancer Therapeutics 6(2): 633-643, 2007

Gallium nitrate for the treatment of non-Hodgkin's lymphoma. Expert Opinion on Investigational Drugs 13(5): 531-541, 2004

Persistent gallium avidity after second-line chemotherapy in Hodgkins disease and intermediate-grade non-Hodgkins lymphoma does not predict outcome following autologous stem cell transplantation. Blood 94(10 SUPPL 1 PART 1): 174a, Nov 15, 1999

Rituximab for the treatment of AIDS-associated non-Hodgkins lymphoma. JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A40, May 1, 1999

Gallium Citrate and Tc-99m Sestamibi in the evaluation of Non-Hodgkins lymphoma Superiority of MIBI in low grade extra-abdominal lymphoma. Blood 96(11 Part 2): 221b, November 16, 2000

Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a 7 day continuous infusion. Cancer 51(11): 1982-1987, 1983

Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. Cancer 51(11): 1982-1987, 1983

Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma. American Journal of Clinical Oncology 20(2): 173-178, 1997

Prognostic factors and treatment outcome in primary progressive Hodgkins lymphoma A report from the German Hodgkins Lymphoma Study Group. Blood 94(10 SUPPL 1 PART 1): 514a, Nov 15, 1999